Catherine R Harris, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Harris’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A111641 · Current
Licensed to practise in California · since 2010 · expires 2027-11-30 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$35,070
Medicare paid this office $35,070 for 207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 47 | $4,845 | $103 |
| Short return visit (20+ min) | 67 | $4,328 | $54 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $2,371 | $62 |
| New patient visit (30+ min) | 26 | $1,740 | $67 |
| Short return visit | 43 | $1,466 | $29 |
See all 8 services
| New patient visit (45+ min) | 47 | $4,845 | $103 |
| Short return visit (20+ min) | 67 | $4,328 | $54 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $2,371 | $62 |
| New patient visit (30+ min) | 26 | $1,740 | $67 |
| Short return visit | 43 | $1,466 | $29 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,286 | $117 |
| Return visit (30+ min) | 13 | $1,060 | $82 |
| Electronic assessment of bladder emptying | 16 | $108 | $7 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
207 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 12% · Women 30% · Also on Medicaid 82% · Health risk score 1.65. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 28% · Coronary heart disease 26% · Cancer 25% · Depression 20% · Heart failure 18% · Atrial fibrillation 18% · COPD 16% · Dementia 11% · Stroke 9%.
The office billed $411,237, Medicare allowed $46,723 and paid $35,070; for 367 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 207 | 367 | 72 | 1.65 | $411,237 | $35,070 |
| 2023 | 175 | 306 | 71 | 1.77 | $371,308 | $32,132 |
| 2022 | 138 | 259 | 73 | 1.54 | $277,882 | $26,783 |
| 2021 | 140 | 272 | 72 | 1.78 | $291,025 | $25,777 |
| 2020 | 152 | 306 | 70 | 2.15 | $325,981 | $30,525 |
| 2019 | 181 | 391 | 70 | 1.94 | $357,709 | $35,399 |
| 2018 | 197 | 448 | 70 | 1.82 | $400,341 | $41,879 |
| 2017 | 193 | 484 | 70 | 1.57 | $457,679 | $48,624 |
| 2016 | 223 | 451 | 69 | 1.84 | $423,270 | $48,833 |
| 2015 | 196 | 362 | 68 | 1.62 | $313,975 | $39,738 |
| 2014 | 39 | 57 | 66 | 1.68 | $55,765 | $10,851 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| New patient visit (45+ min) | 33 | $3,649 | $111 |
| Short return visit (20+ min) | 51 | $3,566 | $57 |
| Return visit (30+ min) | 34 | $2,569 | $73 |
| Diagnostic exam of bladder and urethra using an endoscope | 31 | $2,171 | $62 |
| Short return visit | 44 | $1,438 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,315 | $110 |
2022: 4 services
| Return visit (30+ min) | 73 | $7,638 | $88 |
| Short return visit (20+ min) | 50 | $2,866 | $54 |
| Diagnostic exam of bladder and urethra using an endoscope | 26 | $2,085 | $72 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $631 | $29 |
2021: 4 services
| Return visit (30+ min) | 59 | $6,392 | $94 |
| Short return visit (20+ min) | 30 | $2,198 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 22 | $2,009 | $65 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $1,154 | $30 |
2020: 7 services
| Return visit (30+ min) | 71 | $4,908 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 28 | $2,495 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $2,207 | $100 |
| Biopsy of prostate gland | 18 | $2,163 | $114 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $861 | $48 |
| Short return visit (20+ min) | 17 | $777 | $46 |
| Ultrasound scan of pelvic region through rectum | 14 | $474 | $30 |
2019: 11 services
| Return visit (30+ min) | 50 | $3,891 | $67 |
| New patient visit (45+ min) | 42 | $3,832 | $91 |
| Diagnostic exam of bladder and urethra using an endoscope | 39 | $3,162 | $70 |
| Biopsy of prostate gland | 27 | $2,537 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,733 | $91 |
| Short return visit (20+ min) | 24 | $1,259 | $43 |
| Long return visit (40+ min) | 12 | $1,170 | $97 |
| Ultrasound scan of pelvic region through rectum | 25 | $767 | $27 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $407 | $37 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $190 | $17 |
| Electronic assessment of bladder emptying | 12 | $70 | $6 |
2018: 8 services
| Return visit (30+ min) | 72 | $4,853 | $57 |
| New patient visit (45+ min) | 45 | $4,188 | $93 |
| Diagnostic exam of bladder and urethra using an endoscope | 41 | $3,305 | $66 |
| Biopsy of prostate gland | 16 | $1,894 | $111 |
| Short return visit (20+ min) | 46 | $1,773 | $35 |
| New patient visit (30+ min) | 16 | $680 | $42 |
| Ultrasound scan of pelvic region through rectum | 18 | $547 | $30 |
| Electronic assessment of bladder emptying | 37 | $205 | $5 |
2017: 8 services
| Return visit (30+ min) | 99 | $7,680 | $54 |
| Diagnostic exam of bladder and urethra using an endoscope | 25 | $2,736 | $83 |
| New patient visit (45+ min) | 23 | $2,465 | $107 |
| Short return visit (20+ min) | 52 | $2,296 | $41 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 15 | $1,665 | $111 |
| Insertion of device into abdomen with pressure and urine flow rate study | 16 | $563 | $35 |
| Electronic assessment of bladder emptying | 46 | $324 | $5 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 15 | $246 | $16 |
2016: 6 services
| Return visit (30+ min) | 111 | $8,889 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $2,422 | $97 |
| Short return visit (20+ min) | 50 | $2,233 | $40 |
| Simple change of bladder tube | 23 | $1,321 | $38 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $316 | $16 |
| Electronic assessment of bladder emptying | 23 | $144 | $6 |
2015: 8 services
| Return visit (30+ min) | 52 | $3,920 | $68 |
| Diagnostic exam of bladder and urethra using an endoscope | 36 | $3,429 | $95 |
| Simple change of bladder tube | 24 | $2,157 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,470 | $122 |
| Short return visit (20+ min) | 32 | $1,392 | $41 |
| Ultrasound scan of pelvic region through rectum | 11 | $334 | $30 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $260 | $16 |
| Electronic assessment of bladder emptying | 13 | $83 | $6 |
Medicaid work
$7,336 in 2024
Medicaid paid $7,336 for 1,332 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 156 | $3,792 |
| Change of cystostomy tube; simple | 108 | $1,827 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 51 | $1,316 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 29 | $229 |
| Catheter, drainage | 14 | $121 |
| Short return visit (20+ min) | 12 | $51 |
| Service | 19 | $0 |
| Service | 66 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 19 | $0 |
| Medication list documented in medical record (COA) | 297 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 170 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| 2024 | 1,332 | 16 | 46 | $7,336 |
| 2023 | 407 | 10 | 22 | $4,113 |
| 2022 | 149 | 2 | 17 | $2,150 |
| 2021 | 229 | 2 | 25 | $2,359 |
| 2020 | 76 | 3 | 19 | $1,814 |
| 2019 | 122 | 5 | 16 | $2,173 |
| 2018 | 313 | 5 | 21 | $3,877 |
See the largest Medicaid services in earlier years
2023
| OFF/OP CNSLTJ NEW/EST MOD 40 | 144 | $2,246 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 68 | $873 |
| Short return visit (20+ min) | 27 | $562 |
| CYSTOURETHROSCOPY | 42 | $322 |
| Service | 15 | $62 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 13 | $48 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 19 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 17 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 34 | $0 |
| Catheter, drainage | 28 | $0 |
2022
| Return visit (30+ min) | 84 | $1,230 |
| Short return visit (20+ min) | 65 | $920 |
2021
| Return visit (30+ min) | 167 | $1,709 |
| Short return visit (20+ min) | 62 | $650 |
2020
| OFF/OP CNSLTJ NEW/EST MOD 40 | 49 | $1,362 |
| Return visit (30+ min) | 15 | $296 |
| CYSTOURETHROSCOPY | 12 | $156 |
2019
| Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy (ureteral catheterization is included) | 13 | $1,368 |
| Return visit (30+ min) | 66 | $322 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $292 |
| Short return visit (20+ min) | 16 | $173 |
| CYSTOURETHROSCOPY | 14 | $19 |
2018
| OFF/OP CNSLTJ NEW/EST MOD 40 | 109 | $1,578 |
| Return visit (30+ min) | 113 | $1,023 |
| CYSTOURETHROSCOPY | 36 | $609 |
| Service | 12 | $409 |
| Short return visit (20+ min) | 43 | $257 |
Drugs they prescribed that Part D paid
$57,857
Pharmacies billed $57,857 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 500) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
398 generic and 102 brand-name prescriptions · $57,857 in drug cost · 21 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 72 | $36,831 | $512 |
| Gemtesa | 28 | $13,773 | $492 |
| Oxybutynin Chloride Er | 58 | $1,309 | $23 |
| Finasteride | 109 | $1,173 | $11 |
| Tamsulosin | 114 | $977 | $9 |
See all 9 drugs
| Myrbetriq | 72 | $36,831 | $512 |
| Gemtesa | 28 | $13,773 | $492 |
| Oxybutynin Chloride Er | 58 | $1,309 | $23 |
| Finasteride | 109 | $1,173 | $11 |
| Tamsulosin | 114 | $977 | $9 |
| Trospium Chloride | 16 | $916 | $57 |
| Tolterodine Tartrate Er | 23 | $779 | $34 |
| Potassium Citrate Er | 15 | $665 | $44 |
| Dutasteride | 11 | $156 | $14 |
Year by year
| 2024 | 500 | 89 | 0% (0) | 20% | $57,857 |
| 2023 | 427 | 86 | 0% (0) | 24% | $68,250 |
| 2022 | 527 | 95 | None | 27% | $69,167 |
| 2021 | 597 | 104 | None | 16% | $47,559 |
| 2020 | 527 | 100 | 0% (0) | 12% | $36,717 |
| 2019 | 454 | 119 | None | 15% | $36,598 |
| 2018 | 607 | 134 | None | None | $66,142 |
| 2017 | 516 | 118 | 2% (11) | None | $52,688 |
| 2016 | 356 | 99 | None | 13% | $27,770 |
| 2015 | 82 | 38 | None | None | $4,771 |
| 2014 | 45 | 16 | None | None | $2,746 |
| 2013 | 37 | 16 | None | None | $3,264 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Myrbetriq | 84 | $47,140 | $561 |
| Tamsulosin | 102 | $3,208 | $31 |
| Finasteride | 95 | $2,951 | $31 |
| Tolterodine Tartrate Er | 20 | $2,584 | $129 |
| Potassium Citrate Er | 21 | $2,476 | $118 |
| Trospium Chloride | 30 | $1,812 | $60 |
| Oxybutynin Chloride Er | 32 | $1,663 | $52 |
2022: 7 drugs
| Myrbetriq | 116 | $53,906 | $465 |
| Trospium Chloride | 31 | $2,551 | $82 |
| Tamsulosin | 143 | $2,521 | $18 |
| Oxybutynin Chloride Er | 58 | $2,219 | $38 |
| Finasteride | 97 | $1,742 | $18 |
| Potassium Citrate Er | 12 | $1,431 | $119 |
| Nitrofurantoin | 11 | $538 | $49 |
2021: 9 drugs
| Myrbetriq | 81 | $34,191 | $422 |
| Trospium Chloride | 29 | $2,771 | $96 |
| Finasteride | 146 | $2,153 | $15 |
| Potassium Citrate Er | 13 | $1,910 | $147 |
| Oxybutynin Chloride Er | 57 | $1,870 | $33 |
| Tamsulosin | 179 | $1,683 | $9 |
| Estradiol | 12 | $909 | $76 |
| Oxybutynin Chloride | 18 | $316 | $18 |
| Allopurinol | 11 | $102 | $9 |
2020: 7 drugs
| Myrbetriq | 59 | $23,308 | $395 |
| Trospium Chloride | 22 | $3,611 | $164 |
| Estradiol | 14 | $1,916 | $137 |
| Finasteride | 151 | $1,827 | $12 |
| Oxybutynin Chloride Er | 55 | $1,775 | $32 |
| Tamsulosin | 151 | $1,099 | $7 |
| Oxybutynin Chloride | 23 | $508 | $22 |
2019: 7 drugs
| Myrbetriq | 60 | $23,410 | $390 |
| Finasteride | 111 | $2,280 | $21 |
| Oxybutynin Chloride Er | 76 | $2,258 | $30 |
| Estradiol | 11 | $1,963 | $178 |
| Trospium Chloride | 12 | $1,759 | $147 |
| Tamsulosin | 119 | $1,484 | $12 |
| Oxybutynin Chloride | 14 | $344 | $25 |
2018: 11 drugs
| Myrbetriq | 101 | $38,291 | $379 |
| Elmiron | 12 | $9,708 | $809 |
| Oxybutynin Chloride Er | 74 | $2,862 | $39 |
| Tamsulosin | 124 | $1,955 | $16 |
| Finasteride | 94 | $1,617 | $17 |
| Dutasteride | 26 | $1,195 | $46 |
| Tolterodine Tartrate Er | 14 | $1,095 | $78 |
| Polyethylene Glycol 3350 | 12 | $507 | $42 |
| Oxybutynin Chloride | 24 | $453 | $19 |
| Doxazosin Mesylate | 11 | $276 | $25 |
| Sulfamethoxazole-Trimethoprim | 16 | $67 | $4 |
2017: 11 drugs
| Myrbetriq | 44 | $15,871 | $361 |
| Elmiron | 12 | $14,331 | $1,194 |
| Vesicare | 14 | $4,466 | $319 |
| Trospium Chloride | 18 | $3,125 | $174 |
| Oxybutynin Chloride Er | 81 | $3,075 | $38 |
| Tamsulosin | 99 | $2,163 | $22 |
| Dutasteride | 36 | $2,072 | $58 |
| Finasteride | 83 | $1,499 | $18 |
| Oxybutynin Chloride | 30 | $803 | $27 |
| Ciprofloxacin | 13 | $83 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $38 | $3 |
2016: 8 drugs
| Myrbetriq | 16 | $4,663 | $291 |
| Oxybutynin Chloride Er | 52 | $2,096 | $40 |
| Dutasteride | 18 | $1,970 | $109 |
| Tamsulosin | 79 | $1,619 | $20 |
| Finasteride | 65 | $988 | $15 |
| Polyethylene Glycol 3350 | 12 | $422 | $35 |
| Oxybutynin Chloride | 13 | $291 | $22 |
| Ciprofloxacin | 17 | $117 | $7 |
2015: 2 drugs
| Tamsulosin | 17 | $483 | $28 |
| Finasteride | 16 | $331 | $21 |
Money from drug and device companies
$434 in 2024
| 2024 | 2 | 3 | None | $434 |
| 2023 | 3 | 5 | None | $103 |
| 2022 | 1 | 3 | None | $55 |
| 2020 | 1 | 2 | None | $3,026 |
| 2019 | 1 | 2 | None | $33 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $406 | 2 payments
|
| Coloplast | Luja Coude | $29 | 1 payment
|
See all 3 published payments
| Intuitive Surgical | Meals · 2024-04-11 | Da Vinci Surgical System | $397 |
| Intuitive Surgical | Gift · 2024-04-11 | Da Vinci Surgical System | $9 |
| Coloplast | Meals · 2024-04-10 | Luja Coude | $29 |
See earlier years (2023, 2022, 2020, 2019)
2023: $103
| Abbvie | Lupron Depot | $60 | 3 payments
|
| Becton Dickinson and | Bard Urinary Drainage Bag | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $19 | 1 payment
|
2022: $55
| Abbvie | Avycaz | $55 | 3 payments
|
2020: $3,026
| Intuitive Surgical | Da Vinci Surgical System | $3,026 | 2 payments
|
2019: $33
| Ferring Pharmaceuticals | Nocdurna | $33 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093041626
- Licence
- CA A111641California A111641: Current · expires 2027-11-30
- Trained
- Columbia University College of Physicians and Surgeons, 2008
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 400 Parnassus Ave, A633, San Francisco, CA, 94143
- NPI first listed
- 2009-11-02
- NPI last updated
- 2010-03-25
This is when the NPI record was last certified, not a medical board exam.